- Home
- AWX vs BIAF Comparison
AWX vs BIAF Comparison
Compare AWX & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- BIAF
- Stock Information
- Founded
- AWX 1998
- BIAF 2014
- Country
- AWX United States
- BIAF United States
- Employees
- AWX N/A
- BIAF N/A
- Industry
- AWX Environmental Services
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AWX Utilities
- BIAF Health Care
- Exchange
- AWX Nasdaq
- BIAF Nasdaq
- Market Cap
- AWX 13.6M
- BIAF 12.2M
- IPO Year
- AWX 1998
- BIAF 2022
- Fundamental
- Price
- AWX $2.76
- BIAF $0.68
- Analyst Decision
- AWX
- BIAF Hold
- Analyst Count
- AWX 0
- BIAF 1
- Target Price
- AWX N/A
- BIAF N/A
- AVG Volume (30 Days)
- AWX 14.2K
- BIAF 28.4M
- Earning Date
- AWX 05-07-2025
- BIAF 05-14-2025
- Dividend Yield
- AWX N/A
- BIAF N/A
- EPS Growth
- AWX N/A
- BIAF N/A
- EPS
- AWX 0.34
- BIAF N/A
- Revenue
- AWX $83,795,000.00
- BIAF $9,362,022.00
- Revenue This Year
- AWX N/A
- BIAF $25.19
- Revenue Next Year
- AWX N/A
- BIAF $20.00
- P/E Ratio
- AWX $8.40
- BIAF N/A
- Revenue Growth
- AWX 3.58
- BIAF 269.68
- 52 Week Low
- AWX $2.00
- BIAF $0.24
- 52 Week High
- AWX $3.99
- BIAF $3.16
- Technical
- Relative Strength Index (RSI)
- AWX 39.09
- BIAF 54.71
- Support Level
- AWX $2.48
- BIAF $0.24
- Resistance Level
- AWX $2.90
- BIAF $1.55
- Average True Range (ATR)
- AWX 0.18
- BIAF 0.13
- MACD
- AWX -0.02
- BIAF 0.07
- Stochastic Oscillator
- AWX 31.76
- BIAF 28.99
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.